SPONSOR
Chengdu Suncadia Medicine Co., Ltd.
Total Trials
3
Recruiting
3
Phases
Phase 3, Phase 1
Chengdu Suncadia Medicine Co., Ltd. is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Primary IgA Nephropathy, Heart Failure, B-cell Malignancy.
The trial portfolio spans Phase 3, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Chengdu Suncadia Medicine Co., Ltd.
How many clinical trials has Chengdu Suncadia Medicine Co., Ltd. sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Chengdu Suncadia Medicine Co., Ltd., of which 3 are actively recruiting participants. These trials cover conditions including Primary IgA Nephropathy, Heart Failure, B-cell Malignancy. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Chengdu Suncadia Medicine Co., Ltd. research focus on?
Chengdu Suncadia Medicine Co., Ltd. clinical trials span Primary IgA Nephropathy, Heart Failure, B-cell Malignancy. The research pipeline includes Phase 3, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Chengdu Suncadia Medicine Co., Ltd. clinical trial?
To participate in a Chengdu Suncadia Medicine Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Chengdu Suncadia Medicine Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Chengdu Suncadia Medicine Co., Ltd.
NCT07014826 Phase 3
Recruiting
A Trial of HRS-5965 Capsule in Primary IgA Nephropathy
Primary IgA Nephropathy
NCT07551167 Phase 1
Recruiting
A Clinical Study of HRS-5765 in Healthy Participants
Heart Failure
NCT07583212 Phase 1
Recruiting
Phase I Study of HRS-1635 in B-cell Malignancies
B-cell Malignancy
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology